Articles
no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image
Topics
All | Vitamin & Nutrition | General Information | COVID-19 | Cancer | Cardiology
Stem Cell
Wound Care
Vaccinology
Radiology
Obstetry and Gynecology
Family Medicine
Anesthesiology
Epidemiology
COVID-19
Cancer
Cardiology
Pediatric
Clinical Procedure
Common Diseases
Dental And Oral Health
Dermathology And Aesthetic
Drug
Endocrinology
Eyes
Female
Gastroenterology
General Information
Geriatry
Hematology
Hepatology
Allergy & Immunology
Infection Disease
Inflammation
Male
Mental Health
Mouth Ear Nose
Nephrology
Neurology
Pain
Pathology
Pulmonology
Skeletal & Muscle
Surgery & Recovery
Urology
Vitamin & Nutrition
SPECIAL COVERAGE Featured Article
featured_img
Patients with ER-positive Early Breast Cancer with a Low Risk of Tumor Recurrence Can Safely Avoid Chemotherapy
by dr. Johan Indra Lukito | 05 June 2026
Tumor gene expression tests are widely utilized to assist in adjuvant chemotherapy decisions for patients with early breast cancer (EBC). The OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis) trial investigates the effectiveness of utilizing the Prosigna (PAM50) gene expression test to guide these critical treatment pathways. By comparing a test-directed treatment strategy against standard chemotherapy followed by endocrine therapy, this study aims to personalize care for patients with high clinical risk ER-positive, HER2-negative EBC, particularly focusing on those with node-positive disease.
Comparison of Gla-300 and IDegAsp in Insulin-Naïve Patients with T2DM
by dr. Kayla Audivisi | 02 June 2026
f9622a950beae24c16c89a7aa23a0bb3.jpg
Sitagliptin or Linagliptin in Patients with Type 2 Diabetes: A Meta-Analysis
by dr. Hastarita Lawrenti | 31 May 2026
53eaaeb39696fb52f3e05f66f4701aee.jpg
Latest Articles